Mometasone Stada (Mometasone Furoate)

Mometasone furoate is a potent glucocorticoid that binds to glucocorticoid receptors in the nasal mucosa. The drug‑receptor complex alters gene transcription, decreasing the release of inflammatory cytokines and mediators, which reduces swelling, mucus production, and immune cell infiltration in the nasal passages.

The specific dose and frequency are determined by the prescribing clinician based on the patient’s condition and response. Typically, the product is administered as a few sprays into each nostril once daily, but the exact regimen should follow the prescriber’s instructions and the product label.

Safety data for mometasone furoate in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Mometasone Stada offers a high‑potency anti‑inflammatory effect with once‑daily dosing, similar to other nasal corticosteroids such as fluticasone propionate. Compared with some alternatives, mometasone furoate may have a slightly lower systemic absorption profile, potentially reducing the risk of systemic side effects when used as directed.

Store the nasal spray at ambient temperature, preferably below 25 °C (77 °F). Keep the device in its original packaging, protect it from moisture and direct sunlight, and ensure the cap is tightly closed when not in use to maintain product integrity.

Mometasone Stada is delivered as a metered‑dose nasal spray. The patient should gently blow the nose, tilt the head slightly forward, insert the nozzle into a nostril, and press the actuator while breathing in gently through the nose. The same procedure is repeated in the other nostril if required.

Serious adverse events, though uncommon, include nasal septal perforation, severe allergic reactions such as anaphylaxis, and systemic effects like adrenal suppression when used for prolonged periods or at high doses. Patients should report any unusual bleeding, persistent nasal pain, or signs of systemic corticosteroid exposure to their clinician promptly.

Mometasone Stada is contraindicated in individuals with known hypersensitivity to mometasone furoate or any component of the formulation. It should also be avoided in patients with untreated fungal, bacterial, or viral infections of the nasal passages, as the steroid may worsen these conditions.